메뉴 건너뛰기




Volumn 116, Issue 1, 2015, Pages 5-18

Potential compounds for the treatment of mitochondrial disease

Author keywords

clinical trials; mitochondrial disease; oxidative phosphorylation; therapeutic intervention; treatment

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ACIPIMOX; ARGININE; BEZAFIBRATE; CARNITINE; CYSTEAMINE BIPARTITE; DICHLOROACETIC ACID; DIMETHYLGLYCINE; ELAMIPRETIDE; EPICATECHIN; FLUPIRTINE; IDEBENONE; NICOTINAMIDE RIBOSIDE; OMAVELOXOLONE; POLYPHENOL DERIVATIVE; RAPAMYCIN; THIOCTIC ACID; UBIDECARENONE; UNCLASSIFIED DRUG; VATIQUINONE;

EID: 84950280499     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldv046     Document Type: Article
Times cited : (25)

References (71)
  • 1
    • 84897461671 scopus 로고    scopus 로고
    • Development of pharmacological strategies for mitochondrial disorders
    • Kanabus M, Heales SJ, Rahman S. Development of pharmacological strategies for mitochondrial disorders. Br J Pharmacol 2014;171:1798-817.
    • (2014) Br J Pharmacol , vol.171 , pp. 1798-1817
    • Kanabus, M.1    Heales, S.J.2    Rahman, S.3
  • 2
    • 0019423856 scopus 로고
    • Sequence and organization of the human mitochondrial genome
    • Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature 1981;290:457-65.
    • (1981) Nature , vol.290 , pp. 457-465
    • Anderson, S.1    Bankier, A.T.2    Barrell, B.G.3
  • 3
    • 84928157053 scopus 로고    scopus 로고
    • Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease
    • Gorman GS, Schaefer AM, Ng Y, et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol 2015;77:753-9.
    • (2015) Ann Neurol , vol.77 , pp. 753-759
    • Gorman, G.S.1    Schaefer, A.M.2    Ng, Y.3
  • 6
    • 0035851099 scopus 로고    scopus 로고
    • The ratio of oxidative phosphorylation complexes I-V in bovine heart mitochondria and the composition of respiratory chain supercomplexes
    • Schagger H, Pfeiffer K. The ratio of oxidative phosphorylation complexes I-V in bovine heart mitochondria and the composition of respiratory chain supercomplexes. J Biol Chem 2001;276:37861-7.
    • (2001) J Biol Chem , vol.276 , pp. 37861-37867
    • Schagger, H.1    Pfeiffer, K.2
  • 7
    • 84863874490 scopus 로고    scopus 로고
    • Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10)
    • Horvath R. Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10). J Inherit Metab Dis 2012;35:679-87.
    • (2012) J Inherit Metab Dis , vol.35 , pp. 679-687
    • Horvath, R.1
  • 8
    • 78149325680 scopus 로고    scopus 로고
    • A randomized trial of coenzyme Q10 in mitochondrial disorders
    • Glover EI, Martin J, Maher A, et al. A randomized trial of coenzyme Q10 in mitochondrial disorders. Muscle Nerve 2010;42:739-48.
    • (2010) Muscle Nerve , vol.42 , pp. 739-748
    • Glover, E.I.1    Martin, J.2    Maher, A.3
  • 9
    • 70350136445 scopus 로고    scopus 로고
    • A modern approach to the treatment of mitochondrial disease
    • Parikh S, Saneto R, Falk MJ, et al. A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol 2009;11:414-30.
    • (2009) Curr Treat Options Neurol , vol.11 , pp. 414-430
    • Parikh, S.1    Saneto, R.2    Falk, M.J.3
  • 11
    • 77955283395 scopus 로고    scopus 로고
    • Animal and human studies with the mitochondria-targeted antioxidant MitoQ
    • Smith RAJ, Murphy MP. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci 2010;1201:96-103.
    • (2010) Ann N y Acad Sci , vol.1201 , pp. 96-103
    • Smith, R.A.J.1    Murphy, M.P.2
  • 12
    • 0021744023 scopus 로고
    • Inhibition of lipid peroxidation by a novel compound (CV-2619) in brain mitochondria and mode of action of the inhibition
    • Suno M, Nagaoka A. Inhibition of lipid peroxidation by a novel compound (CV-2619) in brain mitochondria and mode of action of the inhibition. Biochem Biophys Res Commun 1984;125:1046-52.
    • (1984) Biochem Biophys Res Commun , vol.125 , pp. 1046-1052
    • Suno, M.1    Nagaoka, A.2
  • 14
    • 84874322602 scopus 로고    scopus 로고
    • Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy
    • Klopstock T, Metz G, Yu-Wai-Man P, et al. Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy. Brain 2013;136(Pt 2):e230.
    • (2013) Brain , vol.136 , pp. e230
    • Klopstock, T.1    Metz, G.2    Yu-Wai-Man, P.3
  • 15
    • 80052958201 scopus 로고    scopus 로고
    • Idebenone treatment in Leber's hereditary optic neuropathy
    • Carelli V, La Morgia C, Valentino ML, et al. Idebenone treatment in Leber's hereditary optic neuropathy. Brain 2011;134(Pt 9):e188.
    • (2011) Brain , vol.134 , pp. e188
    • Carelli, V.1    La Morgia, C.2    Valentino, M.L.3
  • 16
    • 0035074293 scopus 로고    scopus 로고
    • Cloning of dimethylglycine dehydrogenase and a new human inborn error of metabolism, dimethylglycine dehydrogenase deficiency
    • Binzak BA, Wevers RA, Moolenaar SH, et al. Cloning of dimethylglycine dehydrogenase and a new human inborn error of metabolism, dimethylglycine dehydrogenase deficiency. Am J Hum Genet 2001;68:839-47.
    • (2001) Am J Hum Genet , vol.68 , pp. 839-847
    • Binzak, B.A.1    Wevers, R.A.2    Moolenaar, S.H.3
  • 17
    • 0037241026 scopus 로고    scopus 로고
    • The effect of short-term dimethylglycine treatment on oxygen consumption in cytochrome oxidase deficiency: A double-blind randomized crossover clinical trial
    • Liet J-M, Pelletier V, Robinson BH, et al. The effect of short-term dimethylglycine treatment on oxygen consumption in cytochrome oxidase deficiency: a double-blind randomized crossover clinical trial. J Pediatr 2003;142: 62-6.
    • (2003) J Pediatr , vol.142 , pp. 62-66
    • Liet, J.-M.1    Pelletier, V.2    Robinson, B.H.3
  • 19
    • 0242497007 scopus 로고    scopus 로고
    • Carnitine palmitoyltransferase II deficiency: A clinical, biochemical, and molecular review
    • Sigauke E, Rakheja D, Kitson K, et al. Carnitine palmitoyltransferase II deficiency: a clinical, biochemical, and molecular review. Lab Investig 2003;83:1543-54.
    • (2003) Lab Investig , vol.83 , pp. 1543-1554
    • Sigauke, E.1    Rakheja, D.2    Kitson, K.3
  • 20
    • 20844443983 scopus 로고    scopus 로고
    • L-carnitine and creatine in Friedreich's ataxia. A randomized, placebo-controlled crossover trial
    • Schöls L, Zange J, Abele M, et al. L-carnitine and creatine in Friedreich's ataxia. A randomized, placebo-controlled crossover trial. J Neural Transm 2005;112:789-96.
    • (2005) J Neural Transm , vol.112 , pp. 789-796
    • Schöls, L.1    Zange, J.2    Abele, M.3
  • 21
  • 22
    • 34547683384 scopus 로고    scopus 로고
    • Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol
    • Kato M, Li J, Chuang JL, et al. Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol. Structure 2007;15:992-1004.
    • (2007) Structure , vol.15 , pp. 992-1004
    • Kato, M.1    Li, J.2    Chuang, J.L.3
  • 23
    • 84878480298 scopus 로고    scopus 로고
    • Long-term safety of dichloroacetate in congenital lactic acidosis
    • Abdelmalak M, Lew A, Ramezani R, et al. Long-term safety of dichloroacetate in congenital lactic acidosis. Mol Genet Metab 2013;109:139-43.
    • (2013) Mol Genet Metab , vol.109 , pp. 139-143
    • Abdelmalak, M.1    Lew, A.2    Ramezani, R.3
  • 24
    • 33646202306 scopus 로고    scopus 로고
    • Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial
    • Kaufmann P, Engelstad K, Wei Y, et al. Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology 2006;66:324-30.
    • (2006) Neurology , vol.66 , pp. 324-330
    • Kaufmann, P.1    Engelstad, K.2    Wei, Y.3
  • 25
    • 84890567997 scopus 로고    scopus 로고
    • Mitochondrial bioenergetics and therapeutic intervention in cardiovascular disease
    • Mercer JR. Mitochondrial bioenergetics and therapeutic intervention in cardiovascular disease. Pharmacol Ther 2014;141:13-20.
    • (2014) Pharmacol Ther , vol.141 , pp. 13-20
    • Mercer, J.R.1
  • 26
    • 84855355930 scopus 로고    scopus 로고
    • Initial experience in the treatment of inherited mitochondrial disease with EPI-743
    • Enns GM, Kinsman SL, Perlman SL, et al. Initial experience in the treatment of inherited mitochondrial disease with EPI-743. Mol Genet Metab 2012;105: 91-102.
    • (2012) Mol Genet Metab , vol.105 , pp. 91-102
    • Enns, G.M.1    Kinsman, S.L.2    Perlman, S.L.3
  • 27
    • 84876167339 scopus 로고    scopus 로고
    • Review of clinical trials for mitochondrial disorders: 1997-2012
    • Kerr DS. Review of clinical trials for mitochondrial disorders: 1997-2012. Neurotherapeutics 2013;10:307-19.
    • (2013) Neurotherapeutics , vol.10 , pp. 307-319
    • Kerr, D.S.1
  • 28
    • 77954455562 scopus 로고    scopus 로고
    • Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation
    • Mancuso M, Orsucci D, Logerfo A, et al. Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation. J Neurol 2010; 257:774-81.
    • (2010) J Neurol , vol.257 , pp. 774-781
    • Mancuso, M.1    Orsucci, D.2    Logerfo, A.3
  • 29
    • 0031596641 scopus 로고    scopus 로고
    • Effect of the triaminopyridine flupirtine on calcium uptake, membrane potential and ATP synthesis in rat heart mitochondria
    • Zimmer G, Balakirev M, Zwicker K, et al. Effect of the triaminopyridine flupirtine on calcium uptake, membrane potential and ATP synthesis in rat heart mitochondria. Br J Pharmacol 1998;123:1154-8.
    • (1998) Br J Pharmacol , vol.123 , pp. 1154-1158
    • Zimmer, G.1    Balakirev, M.2    Zwicker, K.3
  • 30
    • 0031792788 scopus 로고    scopus 로고
    • Antioxidant properties of the triaminopyridine, flupirtine
    • Gassen M, Pergande G, Youdim MB. Antioxidant properties of the triaminopyridine, flupirtine. Biochem Pharmacol 1998;56:1323-9.
    • (1998) Biochem Pharmacol , vol.56 , pp. 1323-1329
    • Gassen, M.1    Pergande, G.2    Youdim, M.B.3
  • 31
    • 0034623311 scopus 로고    scopus 로고
    • Protection of mitochondrial integrity from oxidative stress by the triaminopyridine derivative flupirtine
    • Schlüter T, Struy H, Schönfeld P. Protection of mitochondrial integrity from oxidative stress by the triaminopyridine derivative flupirtine. FEBS Lett 2000;481:42-6.
    • (2000) FEBS Lett , vol.481 , pp. 42-46
    • Schlüter, T.1    Struy, H.2    Schönfeld, P.3
  • 32
    • 76049085255 scopus 로고    scopus 로고
    • Freeradical scavenging and mitochondrial antioxidant activities of reishi-ganoderma lucidum (Curt: Fr) P. Karst and arogyapacha-trichopus zeylanicus gaertn extracts
    • Cherian E, Sudheesh NP, Janardhanan KK, et al. Freeradical scavenging and mitochondrial antioxidant activities of Reishi-Ganoderma lucidum (Curt: Fr) P. Karst and Arogyapacha-Trichopus zeylanicus Gaertn extracts. J Basic Clin Physiol Pharmacol 2009;20:289-307.
    • (2009) J Basic Clin Physiol Pharmacol , vol.20 , pp. 289-307
    • Cherian, E.1    Sudheesh, N.P.2    Janardhanan, K.K.3
  • 33
    • 62549137824 scopus 로고    scopus 로고
    • Transcriptome analysis of cadmium response in ganoderma lucidum
    • Chuang HW, Wang IW, Lin SY, et al. Transcriptome analysis of cadmium response in Ganoderma lucidum. FEMS Microbiol Lett 2009;293:205-13.
    • (2009) FEMS Microbiol Lett , vol.293 , pp. 205-213
    • Chuang, H.W.1    Wang, I.W.2    Lin, S.Y.3
  • 34
    • 59649122561 scopus 로고    scopus 로고
    • Effect of ganoderma lucidum on the activities of mitochondrial dehydrogenases and complex I and II of electron transport chain in the brain of aged rats
    • Ajith TA, Sudheesh NP, Roshny D, et al. Effect of Ganoderma lucidum on the activities of mitochondrial dehydrogenases and complex I and II of electron transport chain in the brain of aged rats. Exp Gerontol 2009;44:219-23.
    • (2009) Exp Gerontol , vol.44 , pp. 219-223
    • Ajith, T.A.1    Sudheesh, N.P.2    Roshny, D.3
  • 35
    • 84863620242 scopus 로고    scopus 로고
    • Activating mitochondrial regulator PGC-1α expression by astrocytic NGF is a therapeutic strategy for Huntington's disease
    • Chen L-W, Horng L-Y, Wu C-L, et al. Activating mitochondrial regulator PGC-1α expression by astrocytic NGF is a therapeutic strategy for Huntington's disease. Neuropharmacology 2012;63:719-32.
    • (2012) Neuropharmacology , vol.63 , pp. 719-732
    • Chen, L.-W.1    Horng, L.-Y.2    Wu, C.-L.3
  • 36
    • 84897457350 scopus 로고    scopus 로고
    • First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics
    • Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol 2014;171:2029-50.
    • (2014) Br J Pharmacol , vol.171 , pp. 2029-2050
    • Szeto, H.H.1
  • 37
    • 84897388046 scopus 로고    scopus 로고
    • Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis
    • Birk AV, Chao WM, Bracken C, et al. Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis. Br J Pharmacol 2014;171:2017-28.
    • (2014) Br J Pharmacol , vol.171 , pp. 2017-2028
    • Birk, A.V.1    Chao, W.M.2    Bracken, C.3
  • 38
    • 33751011308 scopus 로고    scopus 로고
    • PGC-1alpha: A key regulator of energy metabolism
    • Liang H, Ward WF. PGC-1alpha: a key regulator of energy metabolism. Adv Physiol Educ 2006;30:145-51.
    • (2006) Adv Physiol Educ , vol.30 , pp. 145-151
    • Liang, H.1    Ward, W.F.2
  • 39
    • 84882827626 scopus 로고    scopus 로고
    • Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy
    • Noe N, Dillon L, Lellek V, et al. Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy. Mitochondrion 2013;13:417-26.
    • (2013) Mitochondrion , vol.13 , pp. 417-426
    • Noe, N.1    Dillon, L.2    Lellek, V.3
  • 40
    • 84856092782 scopus 로고    scopus 로고
    • Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice
    • Yatsuga S, Suomalainen A. Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice. Hum Mol Genet 2012;21:526-35.
    • (2012) Hum Mol Genet , vol.21 , pp. 526-535
    • Yatsuga, S.1    Suomalainen, A.2
  • 41
    • 84897418338 scopus 로고    scopus 로고
    • Turn up the power-pharmacological activation of mitochondrial biogenesis in mouse models
    • Komen JC, Thorburn DR. Turn up the power-pharmacological activation of mitochondrial biogenesis in mouse models. Br J Pharmacol 2014;171:1818-36.
    • (2014) Br J Pharmacol , vol.171 , pp. 1818-1836
    • Komen, J.C.1    Thorburn, D.R.2
  • 42
    • 77953808955 scopus 로고    scopus 로고
    • Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency
    • Bonnefont JP, Bastin J, Laforêt P, et al. Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency. Clin Pharmacol Ther 2010;88:101-8.
    • (2010) Clin Pharmacol Ther , vol.88 , pp. 101-108
    • Bonnefont, J.P.1    Bastin, J.2    Laforêt, P.3
  • 43
    • 84871118476 scopus 로고    scopus 로고
    • Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man
    • Hoffmann E, Wald J, Lavu S, et al. Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man. Br J Clin Pharmacol 2013;75:186-96.
    • (2013) Br J Clin Pharmacol , vol.75 , pp. 186-196
    • Hoffmann, E.1    Wald, J.2    Lavu, S.3
  • 44
    • 84871431259 scopus 로고    scopus 로고
    • A pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers
    • Libri V, Brown AP, Gambarota G, et al. A pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers. PLoS ONE 2012;7:e51395.
    • (2012) PLoS ONE , vol.7 , pp. e51395
    • Libri, V.1    Brown, A.P.2    Gambarota, G.3
  • 45
    • 84897493440 scopus 로고    scopus 로고
    • Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
    • Groenewoud MJ, Zwartkruis FJT. Rheb and mammalian target of rapamycin in mitochondrial homoeostasis. Open Biol 2013;3:130185.
    • (2013) Open Biol , vol.3 , pp. 130185
    • Groenewoud, M.J.1    Zwartkruis, F.J.T.2
  • 46
    • 36749081539 scopus 로고    scopus 로고
    • MTOR controls mitochondrial oxidative function through a YY1-PGC-1α transcriptional complex
    • Cunningham JT, Rodgers JT, Arlow DH, et al. mTOR controls mitochondrial oxidative function through a YY1-PGC-1α transcriptional complex. Nature 2007;450: 736-40.
    • (2007) Nature , vol.450 , pp. 736-740
    • Cunningham, J.T.1    Rodgers, J.T.2    Arlow, D.H.3
  • 47
    • 84890850876 scopus 로고    scopus 로고
    • MTOR inhibition alleviates mitochondrial disease in a mouse model of leigh syndrome
    • Johnson SC, Yanos ME, Kayser E-B, et al. mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Science 2013;342:1524-8.
    • (2013) Science , vol.342 , pp. 1524-1528
    • Johnson, S.C.1    Yanos, M.E.2    Kayser, E.-B.3
  • 48
    • 84880673845 scopus 로고    scopus 로고
    • Pharmacological approaches to restore mitochondrial function
    • Andreux PA, Houtkooper RH, Auwerx J. Pharmacological approaches to restore mitochondrial function. Nat Rev Drug Discov 2013;12:465-83.
    • (2013) Nat Rev Drug Discov , vol.12 , pp. 465-483
    • Andreux, P.A.1    Houtkooper, R.H.2    Auwerx, J.3
  • 49
    • 80055050942 scopus 로고    scopus 로고
    • Screening for active small molecules in mitochondrial complex I deficient Patient's fibroblasts, reveals AICAR as the most beneficial compound
    • Golubitzky A, Dan P, Weissman S, et al. Screening for active small molecules in mitochondrial complex I deficient patient's fibroblasts, reveals AICAR as the most beneficial compound. PLoS ONE 2011;6:e26883.
    • (2011) PLoS ONE , vol.6 , pp. e26883
    • Golubitzky, A.1    Dan, P.2    Weissman, S.3
  • 50
  • 51
    • 69949092670 scopus 로고    scopus 로고
    • Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications
    • Chen J-Q, Cammarata PR, Baines CP, et al. Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim Biophys Acta 2009;1793:1540-70.
    • (2009) Biochim Biophys Acta , vol.1793 , pp. 1540-1570
    • Chen, J.-Q.1    Cammarata, P.R.2    Baines, C.P.3
  • 52
    • 79954490671 scopus 로고    scopus 로고
    • Genistein and folic acid prevent oxidative injury induced by β-amyloid peptide
    • Ding B, Yuan L, Yu H, et al. Genistein and folic acid prevent oxidative injury induced by β-amyloid peptide. Basic Clin Pharmacol Toxicol 2011;108:333-40.
    • (2011) Basic Clin Pharmacol Toxicol , vol.108 , pp. 333-340
    • Ding, B.1    Yuan, L.2    Yu, H.3
  • 53
    • 71849091967 scopus 로고    scopus 로고
    • Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease
    • Beal MF. Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease. Parkinsonism Relat Disord 2009;15(Suppl 3):S189-94.
    • (2009) Parkinsonism Relat Disord , vol.15 , pp. S189-S194
    • Beal, M.F.1
  • 54
    • 84925503952 scopus 로고    scopus 로고
    • A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol
    • Sajish M, Schimmel P. A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol. Nature 2014;519:370-3.
    • (2014) Nature , vol.519 , pp. 370-373
    • Sajish, M.1    Schimmel, P.2
  • 55
    • 79957959973 scopus 로고    scopus 로고
    • Neuroprotective effect of nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis
    • Neymotin A, Calingasan NY, Wille E, et al. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radic Biol Med 2011;51:88-96.
    • (2011) Free Radic Biol Med , vol.51 , pp. 88-96
    • Neymotin, A.1    Calingasan, N.Y.2    Wille, E.3
  • 56
    • 84962030356 scopus 로고    scopus 로고
    • Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans
    • Van de Weijer T, Phielix E, Bilet L, et al. Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans. Diabetes 2015;64:1193-201.
    • (2015) Diabetes , vol.64 , pp. 1193-1201
    • Van De-Weijer, T.1    Phielix, E.2    Bilet, L.3
  • 57
    • 34247271282 scopus 로고    scopus 로고
    • SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress
    • Scher MB, Vaquero A, Reinberg D. SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes Dev 2007;21:920-8.
    • (2007) Genes Dev , vol.21 , pp. 920-928
    • Scher, M.B.1    Vaquero, A.2    Reinberg, D.3
  • 58
    • 84880517634 scopus 로고    scopus 로고
    • The NAD+/Sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling
    • Mouchiroud L, Houtkooper RH, Moullan N, et al. The NAD+/Sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 2013;154:430-41.
    • (2013) Cell , vol.154 , pp. 430-441
    • Mouchiroud, L.1    Houtkooper, R.H.2    Moullan, N.3
  • 59
    • 84901848955 scopus 로고    scopus 로고
    • Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
    • Khan NA, Auranen M, Paetau I, et al. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Mol Med 2014;6:721-31.
    • (2014) EMBO Mol Med , vol.6 , pp. 721-731
    • Khan, N.A.1    Auranen, M.2    Paetau, I.3
  • 60
    • 84902245774 scopus 로고    scopus 로고
    • NAD(+)-dependent activation of sirt1 corrects the phenotype in a mouse model of mitochondrial disease
    • Cerutti R, Pirinen E, Lamperti C, et al. NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease. Cell Metab 2014;19:1042-9.
    • (2014) Cell Metab , vol.19 , pp. 1042-1049
    • Cerutti, R.1    Pirinen, E.2    Lamperti, C.3
  • 61
    • 84862022077 scopus 로고    scopus 로고
    • The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity
    • Cantó C, Houtkooper RH, Pirinen E, et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab 2012;15:838-47.
    • (2012) Cell Metab , vol.15 , pp. 838-847
    • Cantó, C.1    Houtkooper, R.H.2    Pirinen, E.3
  • 63
    • 84859429137 scopus 로고    scopus 로고
    • Molecular pathology of MELAS and L-arginine effects
    • Koga Y, Povalko N, Nishioka J, et al. Molecular pathology of MELAS and L-arginine effects. Biochim Biophys Acta 2012;1820:608-14.
    • (2012) Biochim Biophys Acta , vol.1820 , pp. 608-614
    • Koga, Y.1    Povalko, N.2    Nishioka, J.3
  • 64
    • 84893049149 scopus 로고    scopus 로고
    • Mitochondria: Role of citrulline and arginine supplementation in MELAS syndrome
    • El-Hattab AW, Emrick LT, Chanprasert S, et al. Mitochondria: role of citrulline and arginine supplementation in MELAS syndrome. Int J Biochem Cell Biol 2014;48:85-91.
    • (2014) Int J Biochem Cell Biol , vol.48 , pp. 85-91
    • El-Hattab, A.W.1    Emrick, L.T.2    Chanprasert, S.3
  • 65
    • 84867895466 scopus 로고    scopus 로고
    • Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders
    • El-Hattab AW, Emrick LT, Craigen WJ, et al. Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders. Mol Genet Metab 2012;107:247-52.
    • (2012) Mol Genet Metab , vol.107 , pp. 247-252
    • El-Hattab, A.W.1    Emrick, L.T.2    Craigen, W.J.3
  • 66
    • 78649711229 scopus 로고    scopus 로고
    • Abnormal myocardial energy-production state in mitochondrial cardiomyopathy and acute response to L-arginine infusion. C-11 acetate kinetics revealed by positron emission tomography
    • Arakawa K, Kudo T, Ikawa M, et al. Abnormal myocardial energy-production state in mitochondrial cardiomyopathy and acute response to L-arginine infusion. C-11 acetate kinetics revealed by positron emission tomography. Circ J 2010;74:2702-11.
    • (2010) Circ J , vol.74 , pp. 2702-2711
    • Arakawa, K.1    Kudo, T.2    Ikawa, M.3
  • 67
    • 84930638309 scopus 로고    scopus 로고
    • L-arginine affects aerobic capacity and muscle metabolism in MELAS (Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes) syndrome
    • Rodan LH, Wells GD, Banks L, et al. L-Arginine affects aerobic capacity and muscle metabolism in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) syndrome. PLoS ONE 2015;10:e0127066.
    • (2015) PLoS ONE , vol.10 , pp. e0127066
    • Rodan, L.H.1    Wells, G.D.2    Banks, L.3
  • 68
    • 84879689589 scopus 로고    scopus 로고
    • Effects of (-)-epicatechin and derivatives on nitric oxide mediated induction of mitochondrial proteins
    • Moreno-Ulloa A, Cid A, Rubio-Gayosso I, et al. Effects of (-)-epicatechin and derivatives on nitric oxide mediated induction of mitochondrial proteins. Bioorg Med Chem Lett 2013;23:4441-6.
    • (2013) Bioorg Med Chem Lett , vol.23 , pp. 4441-4446
    • Moreno-Ulloa, A.1    Cid, A.2    Rubio-Gayosso, I.3
  • 69
    • 80052793189 scopus 로고    scopus 로고
    • Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle
    • Nogueira L, Ramirez-Sanchez I, Perkins GA, et al. (-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle. J Physiol 2011;589(Pt 18): 4615-31.
    • (2011) J Physiol , vol.589 , pp. 4615-4631
    • Nogueira, L.1    Ramirez-Sanchez, I.2    Perkins, G.A.3
  • 70
    • 84867763101 scopus 로고    scopus 로고
    • Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the disease
    • Garrido-Maraver J, Cordero MD, Moñino ID, et al. Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the disease. Br J Pharmacol 2012;167:1311-28.
    • (2012) Br J Pharmacol , vol.167 , pp. 1311-1328
    • Garrido-Maraver, J.1    Cordero, M.D.2    Moñino, I.D.3
  • 71
    • 77953622439 scopus 로고    scopus 로고
    • The neuroophthalmology of mitochondrial disease
    • Fraser JA, Biousse V, Newman NJ. The neuroophthalmology of mitochondrial disease. Surv Ophthalmol 2010;55:299-334.
    • (2010) Surv Ophthalmol , vol.55 , pp. 299-334
    • Fraser, J.A.1    Biousse, V.2    Newman, N.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.